Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02751853
Other study ID # 16-011
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date December 2016
Est. completion date August 31, 2022

Study information

Verified date September 2022
Source University of Luebeck
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aim of the study is to assess the effects of abruptly increased afterload on left ventricular contractility and relaxation in patients with heart failure with preserved ejection fraction (HFPEF), patients with heart failure with reduced ejection fraction (HFREF), and patients without HFPEF or HFREF.


Recruitment information / eligibility

Status Terminated
Enrollment 20
Est. completion date August 31, 2022
Est. primary completion date August 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Clinical indication for left and right heart catheterization - HFPEF (Group 1) OR HFREF (Group 2) OR absent echocardiographic evidence of HFREF OR HFPEF(Group 3) AND - Sinus rhythm during invasive measurements - Age =18 years - Negative pregnancy test in women with childbearing potential - Written informed consent Exclusion Criteria: - Acute coronary syndrome - Acute myocardial infarction <6 months - Planned cardiac surgery or cardiovascular intervention within 6 months following inclusion - Valvular heart disease >2° - Severe comorbidities with limited life expectancy <12 months - Precapillary pulmonary hypertension - Participation in another trial

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Conductance catheter
Continuous online measurements of left ventricular pressure and volume using conductance catheters

Locations

Country Name City State
Germany Universitätsklinikum Schleswig-Holstein Lübeck Schleswig-Holstein

Sponsors (1)

Lead Sponsor Collaborator
University of Luebeck

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hemodynamic parameter 1: Changes in contractility assessed by the end-systolic pressure-volume relationship Changes in contractility after handgrip exercise assessed by the end-systolic pressure-volume relationship Day 1
Secondary Hemodynamic parameter 2: Changes in contractility assessed by the peak power index Changes in contractility after handgrip exercise assessed by the peak power index Day 1
Secondary Hemodynamic parameter 3: Changes in relaxation assessed by the relaxation constant "tau" Changes in relaxation after handgrip exercise assessed by the relaxation constant "tau" Day 1
Secondary Functional parameter: Changes in ejection fraction Changes in ejection fraction after handgrip exercise assessed by echocardiography Day 1
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy